UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SEC FILE NUMBER: 0-10783
CUSIP NUMBER: 055662100
(Check One): [ ] Form 10-K [ ] Form 20-F
[ ] Form 11-K [X] Form 10-Q
[ ] Form N-SAR
For Period Ended: November 30, 1996
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: _____________________
____________________________________________________________
_
PART I - REGISTRANT INFORMATION
____________________________________________________________
_
Full Name of Registrant: BSD Medical Corporation
Former Name if Applicable: N/A
Address of Principal Executive Office: 2188 West 2200 South
City, State and Zip Code: Salt Lake City, UT 84119
____________________________________________________________
_
PART II - RULES 12b-25(b) AND (c)
____________________________________________________________
_
If the subject report could not be filed without
unreasonable effort or expense and the registrant seeks
relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in
Part III of this form could not be eliminated
without unreasonable effort or expense;
(b) The subject annual report, semi-annual report,
transition report on Form 10-K, Form 20-F, 11-K or
Form N-SAR, or portion thereof, will be filed on or
before the fifteenth calendar day following the
prescribed due date; or the subject quarterly
report or transition
[X] report on Form 10-Q, or portion thereof will be
filed on or before the fifth calendar day following
the prescribed due date; and
(c) The accountant's statement or other exhibit
required by Rule 12b-25(c) has been attached if
applicable.
____________________________________________________________
_
PART III - NARRATIVE
____________________________________________________________
_
State below in reasonable detail the reasons why the Form 10-
K, 20-F, 11-K, 10-Q, N-SAR, or the transition report or
portion thereof, could not be filed within the prescribed
time period.
The Company is unable to file its Form 10-QSB for the
quarter ended November 30, 1996, because it has not yet
received its audited financial statements needed to file its
1996 10-KSB. As the 10-QSB financial statements are based
upon the audited statements from the 10-KSB, the Company
cannot file the 10-QSB until it receives the audited
financial statements. The Company should receive these
statements within a few days.
____________________________________________________________
_
PART IV - OTHER INFORMATION
____________________________________________________________
_
(1)Name and telephone number of person to contact in regard
to this notification:
Paul F. Turner 801 972-5555
(Name) (Area Code) (Telephone Number)
(2)Have all other periodic reports required under Section
13 or 15(d) of the Securities Exchange Act of 1934 or
Section 30 of the Investment Company Act of 1940 during
the preceding 12 months or for such shorter period that
the registrant was required to file such report(s) been
filed? If answer is no, identify report(s). [ ] Yes
[X] No
The Company's annual reports on Form 10-KSB for the
fiscal years ended August 31, 1995, and August 31, 1996,
have not yet been filed with the Commission. The annual
reports will be filed at the same time as the subject
report.
(3)Is it anticipated that any significant change in results
of operations from the corresponding period for the last
fiscal year will be reflected by the earnings statements
to be included in the subject report or portion thereof?
[ ] Yes [X] No
If so, attach an explanation of the anticipated change,
both narratively and quantitatively, and, if
appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
BSD Medical Corporation
__________________________________
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by
the undersigned thereunto duly authorized.
Date: January 14, 1997 By: /s/ Paul F. Turner
______________
Paul F. Turner
Chairman, Acting President,
and
Sr. V.P. of Research and
Development
INSTRUCTION: The form may be signed by an executive officer
of the registrant or by any other duly authorized
representative. The name and title of the person signing
the form shall be typed or printed beneath the signature.
If the statement is signed on behalf of the registrant by an
authorized representative (other than an executive officer),
evidence of the representative's authority to sign on behalf
of the registrant shall be filed with the form.
____________________________________________________________
_
ATTENTION
Intentional misstatements or omissions of fact constitute
Federal Criminal Violations (see 18 U.S.C. 1001).
____________________________________________________________
_
GENERAL INSTRUCTIONS
1.This Form is required by Rule 12b-25 (17 CFR 240.12b-25)
of the General Rules and Regulations under the Securities
and Exchange Act of 1934.
2.One signed original and four conformed copies of this
Form and amendments thereto must be completed and filed
with the Securities and Exchange Commission, Washington,
D.C. 20549, in accordance with Rule 0-3 of the General
Rules and Regulations under the Act. The information
contained in or filed with the form will be made a matter
of the public record in the Commission files.
3.A manually signed copy of the Form and amendments thereto
shall be filed with each national securities exchange on
which any class of securities of the registrant is
registered.
4.Amendments to the notifications must also be filed on
Form 12b-25 but need not restate information that has
been correctly furnished. The Form shall be clearly
identified as an amended notification.
5.Electronic Filers. This form shall not be used by
electronic filers unable to timely file a report solely
due to electronic difficulties. Filers unable to submit
a report within the time period prescribed due to
difficulties in electronic filing should comply with
either Rule 201 or Rule 202 of Regulation S-T (232.201 or
232.202 of this chapter) or apply for an adjustment in
filing date pursuant to Rule 13(b) of Regulation S-T
(232.13(b) of this chapter).
